Gf Fund Management Co. Ltd. Igm Biosciences, Inc. Transaction History
Gf Fund Management Co. Ltd.
- $4.62 Trillion
- Q4 2024
A detailed history of Gf Fund Management Co. Ltd. transactions in Igm Biosciences, Inc. stock. As of the latest transaction made, Gf Fund Management Co. Ltd. holds 716 shares of IGMS stock, worth $988. This represents 0.0% of its overall portfolio holdings.
Number of Shares
716Holding current value
$988% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding IGMS
# of Institutions
86Shares Held
19.5MCall Options Held
61.3KPut Options Held
36.7K-
Baker Bros. Advisors LP New York, NY4.09MShares$5.65 Million0.28% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.57MShares$4.93 Million0.0% of portfolio
-
Siren, L.L.C. New York, NY3.33MShares$4.6 Million0.9% of portfolio
-
Redmile Group, LLC San Francisco, CA2.95MShares$4.07 Million1.41% of portfolio
-
Goldman Sachs Group Inc New York, NY978KShares$1.35 Million0.0% of portfolio
About IGM Biosciences, Inc.
- Ticker IGMS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,969,000
- Market Cap $40M
- Description
- IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...